Evidence Hub

Validation of Simplified Renal Dosimetry Protocols for 177Lu-DOTATATE Therapy Using the IDAC-dose Software

Yokouchi A, Shibutani T, Konishi T, Yoneyama H, Ichikawa H, Wakabayashi H

Molecular imaging and radionuclide therapy, 2026

17 participants · 1 citation

Abstract

Objectives: The multi-time-point imaging method for renal dosimetry in lutetium-177 (177Lu)-DOTATATE therapy imposes a significant burden. This study aimed to validate simplified two-time-point (2TP) and three-time-point (3TP) protocols using the International Commission on Radiological Protection-compliant IDAC-Dose 2.1 software.

Methods: This retrospective study analyzed 28 kidneys obtained from 17 patients with neuroendocrine neoplasms. Renal absorbed doses from a reference four-time-point (4TP) schedule (4, 24, 72, and 120 hours) were compared with ten simplified protocols using statistical analyses of error and agreement.

Results: Protocols that included the 120-hour time point demonstrated significantly higher accuracy. The 2TP (4, 24) protocol showed a profound underestimation [mean percentage error (MPE): -14.3%] and a high error. In contrast, the 2TP (24, 120) protocol showed excellent agreement [MPE: 0.57%, mean absolute percent error (MAPE): 5.5%]. Among 3TP methods, the 3TP (24, 72, 120) protocol yielded the highest accuracy (MAPE: 1.97%).

Conclusion: Accurate renal dosimetry in 177Lu-DOTATATE therapy can be achieved with simplified protocols. Incorporating a late-phase time point (around 120 hours) is essential for reliable estimation. The 2TP (24, 120) and 3TP (24, 72, 120) combinations are suggested as feasible alternatives to the standard 4TP method.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free